the tests available to customize their therapy.
Genomic testing like the Oncotype DX® test examines tumor genes for over- or under-activity. Dr. Kaklamani says the Oncotype DX Breast Recurrence Score® tells patients and doctors how aggressive their cancer is and the risk of it returning, and if chemotherapy may be beneficial or safely omitted.
“The wonderful thing about the [Oncotype® test] result is that it’s particular to the lady we’re testing,” she explains. “When I speak to someone about breast cancer, none of the hundreds of women in our clinical studies are in my office. Each test reflects that woman’s breast cancer.”
Asking your doctor about genetic testing may help guarantee you receive a personalized cancer treatment plan. After all, you wouldn’t take someone else’s prescription drug, would you?
Should I Be Doing A Self-Breast Exam?
Dr. Kaklamani believes you should always monitor your breast health even if the American Cancer Society stopped advocating self-exams in 2015.
She adds “breast self-awareness” is necessary by the guidelines. “It’s crucial to know what your breasts look like and to consult your doctor if anything changes.”
Dr. Kaklmani states that one research found that nurses who were appropriately educated in self-breast checks could identify their breast cancer. She recommends asking your gynecologist or primary care doctor for guidance.